1-4 of 4
Martin R. Weihrauch
Close
Sort by
Journal Articles

First Report and Results From VSCO.NET, the Virtual Society of Clinical Oncology, An Independent Internet-Based Haematology/Oncology Platform.

Martin R Weihrauch, Florian Brinker, Jonas Breuer
Journal: Blood
Blood (2010) 116 (21): 3832.
https://doi.org/10.1182/blood.V116.21.3832.3832
Published: 2010
Journal Articles

MGN1703, a Novel TLR9-Agonist - Results of a Phase 1 Clinical Trial in Patients with Metastatic Malignancies.

Martin R Weihrauch, Manuel Schmidt, Marina Tschaika, Heike Richly, Michael S von Bergwelt-Baildon, Ulrich Hacker, Alexander Shimabokuro-Vornhagen, Burghardt Wittig, Max E Scheulen
Journal: Blood
Blood (2009) 114 (22): 4730.
https://doi.org/10.1182/blood.V114.22.4730.4730
Published: 2009
Journal Articles

In vivo peripheral expansion of naive CD4 + CD25 high FoxP3 + regulatory T cells in patients with multiple myeloma

Marc Beyer, Matthias Kochanek, Thomas Giese, Elmar Endl, Martin R. Weihrauch, Percy A. Knolle, Sabine Classen, Joachim L. Schultze
Journal: Blood
Blood (2006) 107 (10): 3940–3949.
https://doi.org/10.1182/blood-2005-09-3671
Published: 2006
Includes: Supplemental data
Journal Articles

Thoracic positron emission tomography using 18 F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

Clinical Trials & Observations
Martin R. Weihrauch, Daniel Re, Klemens Scheidhauer, Sascha Ansén, Markus Dietlein, Stefanie Bischoff, Heribert Bohlen, Jürgen Wolf, Harald Schicha, Volker Diehl, Hans Tesch
Journal: Blood
Blood (2001) 98 (10): 2930–2934.
https://doi.org/10.1182/blood.V98.10.2930
Published: 2001